Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure.

Hernandez AF, Fonarow GC, Hammill BG, Al-Khatib SM, Yancy CW, O'Connor CM, Schulman KA, Peterson ED, Curtis LH.

Circ Heart Fail. 2010 Jan;3(1):7-13. doi: 10.1161/CIRCHEARTFAILURE.109.884395. Epub 2009 Dec 15.

2.

Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.

Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, Chow T.

Circ Cardiovasc Qual Outcomes. 2009 Jan;2(1):16-24. doi: 10.1161/CIRCOUTCOMES.108.807123. Epub 2009 Jan 6.

3.

Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.

Al-Khatib SM, Hellkamp AS, Fonarow GC, Mark DB, Curtis LH, Hernandez AF, Anstrom KJ, Peterson ED, Sanders GD, Al-Khalidi HR, Hammill BG, Heidenreich PA, Hammill SC.

JAMA. 2014 Jun 4;311(21):2209-15. doi: 10.1001/jama.2014.5310.

4.
5.

Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation.

Ptaszek LM, Wang PJ, Hunt SA, Valantine H, Perlroth M, Al-Ahmad A.

Heart Rhythm. 2005 Sep;2(9):931-3.

PMID:
16171746
6.

Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.

Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4):429-35.

PMID:
16255753
7.

Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction.

Ermis C, Lurie KG, Zhu AX, Collins J, Vanheel L, Sakaguchi S, Lu F, Pham S, Benditt DG.

J Cardiovasc Electrophysiol. 2004 Aug;15(8):862-6.

PMID:
15333075
8.

Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly.

Groeneveld PW, Farmer SA, Suh JJ, Matta MA, Yang F.

Heart Rhythm. 2008 May;5(5):646-53. doi: 10.1016/j.hrthm.2008.01.038. Epub 2008 Jan 29.

PMID:
18452864
9.

Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.

Sanders GD, Kong MH, Al-Khatib SM, Peterson ED.

Am Heart J. 2010 Jul;160(1):122-31. doi: 10.1016/j.ahj.2010.04.021.

PMID:
20598982
10.

Quality of care and outcomes in women hospitalized for heart failure.

Klein L, Grau-Sepulveda MV, Bonow RO, Hernandez AF, Williams MV, Bhatt DL, Fonarow GC.

Circ Heart Fail. 2011 Sep;4(5):589-98. doi: 10.1161/CIRCHEARTFAILURE.110.960484. Epub 2011 Aug 23.

11.

Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.

Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy CW, Albert NM, Peterson ED.

JAMA. 2007 Oct 3;298(13):1525-32.

PMID:
17911497
12.

Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.

Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC, Peterson ED; Get With The Guidelines Steering Committee.

J Am Coll Cardiol. 2009 Feb 3;53(5):416-22. doi: 10.1016/j.jacc.2008.09.045.

13.

Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.

Borne RT, Peterson PN, Greenlee R, Heidenreich PA, Wang Y, Curtis JP, Tzou WS, Varosy PD, Kremers MS, Masoudi FA.

Circulation. 2014 Sep 2;130(10):845-53. doi: 10.1161/CIRCULATIONAHA.114.008653. Epub 2014 Aug 5.

14.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

15.

Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.

K├╝hne M, Sakumura M, Reich SS, Sarrazin JF, Wells D, Chalfoun N, Crawford T, Boonyapisit W, Horwood L, Chugh A, Good E, Jongnarangsin K, Bogun F, Oral H, Morady F, Pagani F, Pelosi F Jr.

Am J Cardiol. 2010 Feb 1;105(3):378-82. doi: 10.1016/j.amjcard.2009.09.044. Epub 2009 Dec 22.

PMID:
20102952
16.
17.

A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study.

Dubner S, Valero E, Pesce R, Zuelgaray JG, Mateos JC, Filho SG, Reyes W, Garillo R.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4):420-8.

PMID:
16255752
18.

Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).

Fonarow GC, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Hospitals.

Arch Intern Med. 2007 Jul 23;167(14):1493-502.

PMID:
17646603
19.

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.

Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.

PMID:
19752408
20.

Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator.

Fonarow GC, Feliciano Z, Boyle NG, Knight L, Woo MA, Moriguchi JD, Laks H, Wiener I.

Am J Cardiol. 2000 Apr 15;85(8):981-5.

PMID:
10760339
Items per page

Supplemental Content

Write to the Help Desk